[HTML][HTML] The role of inflammation in diabetes: current concepts and future perspectives

S Tsalamandris, AS Antonopoulos… - European cardiology …, 2019 - ncbi.nlm.nih.gov
Diabetes is a complex metabolic disorder affecting the glucose status of the human body.
Chronic hyperglycaemia related to diabetes is associated with end organ failure. The clinical …

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

M Foretz, B Guigas, B Viollet - Nature Reviews Endocrinology, 2019 - nature.com
Despite its position as the first-line drug for treatment of type 2 diabetes mellitus, the
mechanisms underlying the plasma glucose level-lowering effects of metformin (1, 1 …

Master regulator activating transcription factor 3 (ATF3) in metabolic homeostasis and cancer

HC Ku, CF Cheng - Frontiers in Endocrinology, 2020 - frontiersin.org
Activating transcription factor 3 (ATF3) is a stress-induced transcription factor that plays vital
roles in modulating metabolism, immunity, and oncogenesis. ATF3 acts as a hub of the …

Metformin, macrophage dysfunction and atherosclerosis

X Feng, W Chen, X Ni, PJ Little, S Xu, L Tang… - Frontiers in …, 2021 - frontiersin.org
Metformin is one of the most widely prescribed hypoglycemic drugs and has the potential to
treat many diseases. More and more evidence shows that metformin can regulate the …

Metformin improves obesity-associated inflammation by altering macrophages polarization

Y Jing, F Wu, D Li, L Yang, Q Li, R Li - Molecular and cellular …, 2018 - Elsevier
Obesity is reported to be a chronic low-grade inflammatory state. Adipose tissue
macrophages play a key role in obesity-related inflammation. Metformin, the most widely …

Metformin as an anti-inflammatory agent: a short review

R Kristófi, JW Eriksson - Journal of Endocrinology, 2021 - joe.bioscientifica.com
Metformin is a biguanide drug widely used as the initial treatment of type 2 diabetes. Despite
its widespread use, its precise mechanisms of action remain incompletely characterised. Its …

[HTML][HTML] Metformin induces the M2 macrophage polarization to accelerate the wound healing via regulating AMPK/mTOR/NLRP3 inflammasome singling pathway

L Qing, J Fu, P Wu, Z Zhou, F Yu… - American journal of …, 2019 - ncbi.nlm.nih.gov
Background: Skin wound healing is a challenging problem, especially in aging or diabetic
patients, which becomes more difficult to heal, and easily results in considerable public …

Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management

F Luo, A Das, J Chen, P Wu, X Li, Z Fang - Cardiovascular Diabetology, 2019 - Springer
With an increasing global burden of coronary artery disease (CAD), early detection and
timely management of risk factors are crucial to reduce morbidity and mortality in such …

Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data

L Nesti, A Natali - Nutrition, Metabolism and Cardiovascular Diseases, 2017 - Elsevier
Background Metformin, the eldest and most widely used glucose lowering drug, is likely to
be effective also on cardiac and vascular disease prevention. Nonetheless, uncertainty still …

Metformin and autoimmunity: a “new deal” of an old drug

F Ursini, E Russo, G Pellino, S D'Angelo… - Frontiers in …, 2018 - frontiersin.org
Metformin (dimethyl biguanide) is a synthetic derivative of guanidine, isolated from the
extracts of Galega officinalis, a plant with a prominent antidiabetic effect. Since its discovery …